The goal of the collaboration is to rapidly improve care for patients with tumors that form from hormone-releasing cells.

A new study finds surprisingly low genetic testing rates for cancer patients who may benefit, especially among Asian, Black and Hispanic patients.

The solution to the overdiagnosis and overtreatment of prostate cancer could lie in every man’s genome. Stanford Medicine researchers take a step toward genetically personalized cancer screening.

An international effort led by a Stanford Medicine researcher finds more than 50 genes linked to glioma — a rare brain cancer. Although most gliomas are sporadic, a minority are inherited.

Most children receiving radiation therapy for cancer can hold still without anesthesia if they watch videos during the treatment, a study of a technique developed at Stanford Medicine found.

Triple-negative breast cancer patients who used antibiotics within three years of diagnosis have an increased risk of death, according to a study. The gut microbiome is a likely link.

In a study led by Stanford Medicine, researchers harnessed the skin’s immune response to bacteria to create an immunotherapy — delivered by swab — that treats aggressive tumors in mice.

Tiny circles of DNA harbor cancer-associated oncogenes and immunomodulatory genes promoting cancer development. They arise during transformation from pre-cancer to cancer, say Stanford Medicine-led team.

A novel Stanford School of Medicine partnership uncovers a direct link between a cancer-associated gene, Myc, and sugar patterns on cancer cell surfaces that tell immune cells to stand down.

Researchers found that when they turned cancer cells into immune cells, they were able to teach other immune cells how to attack cancer.